[Ala107]MBP (104-118) (TFA)

OC(C(F)(F)F)=O.O=C(CN)N[C@H](C(NCC(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(O)=O)C)=O)=O)CC1=CNC2=CC=CC=C12)=O)CO)=O)CC3=CC=CC=C3)=O)CCCNC(N)=N)=O)CO)=O)CC(C)C)=O)CO)=O)CC(C)C)=O)=O)C)=O)=O)CCCCN

[1]Su HD, et, al. Synthetic myelin basic protein peptide analogs are specific inhibitors of phospholipid/calcium-dependent protein kinase (protein kinase C) . Biochem Biophys Res Commun. 1986 Jan 14; 134 (1) : 78-84.